{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:38:21Z","timestamp":1792633101945,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI072726"],"award-info":[{"award-number":["R01AI072726"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI157274"],"award-info":[{"award-number":["R01AI157274"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL139766"],"award-info":[{"award-number":["R01HL139766"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL159297"],"award-info":[{"award-number":["R01HL159297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.rdc.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T01:23:05Z","timestamp":1679016185000},"page":"647-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Kawasaki Disease and Multisystem Inflammatory Syndrome in Children"],"prefix":"10.1016","volume":"49","author":[{"given":"Magali","family":"Noval Rivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Arditi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.rdc.2023.03.002_bib1","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.rdc.2023.03.002_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"JAMA"},{"issue":"10239","key":"10.1016\/j.rdc.2023.03.002_bib3","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rdc.2023.03.002_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/jama.2020.10374","article-title":"Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City","volume":"324","author":"Cheung","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2023.03.002_bib5","doi-asserted-by":"crossref","first-page":"m2094","DOI":"10.1136\/bmj.m2094","article-title":"Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study","volume":"369","author":"Toubiana","year":"2020","journal-title":"BMJ"},{"issue":"10237","key":"10.1016\/j.rdc.2023.03.002_bib6","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.rdc.2023.03.002_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.120.048360","article-title":"Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic","volume":"142","author":"Belhadjer","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.rdc.2023.03.002_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2023.03.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2020.06.057","article-title":"Multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease: two different illnesses with overlapping clinical features","author":"Rowley","year":"2020","journal-title":"J Pediatrics"},{"key":"10.1016\/j.rdc.2023.03.002_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000003449","article-title":"Distinguishing multisystem inflammatory syndrome in children from COVID-19, Kawasaki Disease and toxic shock syndrome","author":"Godfred-Cato","year":"2022","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.rdc.2023.03.002_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11926-020-0882-1","article-title":"A comprehensive update on Kawasaki Disease vasculitis and myocarditis","volume":"22","author":"Soni","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/1756-185X.13213","article-title":"Is Kawasaki disease an infectious disorder?","volume":"21","author":"Rowley","year":"2018","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2023.03.002_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/428291","article-title":"Association between a novel human coronavirus and Kawasaki disease","volume":"191","author":"Esper","year":"2005","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.rdc.2023.03.002_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jfma.2013.12.008","article-title":"Viral infections associated with Kawasaki disease","volume":"113","author":"Chang","year":"2014","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.rdc.2023.03.002_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1086\/430797","article-title":"Lack of association between New Haven coronavirus and Kawasaki disease","volume":"192","author":"Ebihara","year":"2005","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.rdc.2023.03.002_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1086\/431609","article-title":"Kawasaki disease and human coronavirus","volume":"192","author":"Belay","year":"2005","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"10.1016\/j.rdc.2023.03.002_bib17","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/509509","article-title":"Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome","volume":"194","author":"Dominguez","year":"2006","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/infdis\/jiaa066","article-title":"A protein epitope targeted by the antibody response to Kawasaki Disease","volume":"222","author":"Rowley","year":"2020","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.rdc.2023.03.002_bib19","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/infdis\/jiaa253","article-title":"High-throughput screening of Kawasaki Disease sera for antiviral antibodies","volume":"222","author":"Quiat","year":"2020","journal-title":"J Infect Dis"},{"issue":"25","key":"10.1016\/j.rdc.2023.03.002_bib20","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.121.054785","article-title":"Reduction in Kawasaki Disease after nonpharmaceutical interventions in the COVID-19 era: a nationwide observational study in Korea","volume":"143","author":"Kang","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.rdc.2023.03.002_bib21","doi-asserted-by":"crossref","first-page":"e2217436","DOI":"10.1001\/jamanetworkopen.2022.17436","article-title":"Epidemiological and clinical features of Kawasaki disease during the COVID-19 pandemic in the United States","volume":"5","author":"Burney","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.rdc.2023.03.002_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamapediatrics.2021.0630","article-title":"Trends in geographic and temporal distribution of us children with multisystem inflammatory syndrome during the COVID-19 Pandemic","volume":"175","author":"Belay","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"3","key":"10.1016\/j.rdc.2023.03.002_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MD.0b013e3181df193c","article-title":"Kawasaki disease in adults: report of 10 cases","volume":"89","author":"Gomard-Mennesson","year":"2010","journal-title":"Medicine"},{"issue":"40","key":"10.1016\/j.rdc.2023.03.002_bib24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.15585\/mmwr.mm6940e1","article-title":"Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March-August 2020","volume":"69","author":"Morris","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.rdc.2023.03.002_bib25","first-page":"e23682","article-title":"Multisystem inflammatory syndrome in children: a case report from Japan","volume":"14","author":"Hisamura","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.rdc.2023.03.002_bib26","doi-asserted-by":"crossref","first-page":"e01493","DOI":"10.1016\/j.idcr.2022.e01493","article-title":"A\u00a0young child with pediatric multisystem inflammatory syndrome successfully treated with high-dose immunoglobulin therapy","volume":"28","author":"Mohri","year":"2022","journal-title":"IDCases"},{"key":"10.1016\/j.rdc.2023.03.002_bib27","unstructured":"CDC. Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States. Available at: https:\/\/covidcdcgov\/covid-data-tracker\/#mis-national-surveillance. Accessed November 7, 2022."},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/1756-185X.13218","article-title":"The genetics of Kawasaki disease","volume":"21","author":"Onouchi","year":"2018","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2023.03.002_bib29","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","article-title":"Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1","volume":"146","author":"Lee","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2023.03.002_bib30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jaci.2021.06.024","article-title":"Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C)","volume":"148","author":"Chou","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.rdc.2023.03.002_bib31","doi-asserted-by":"crossref","unstructured":"Benamar M, Chen Q, Chou J, et al. The Notch1\/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children. J Clin Invest. 2023 Jan 3;133(1):e163235. doi: 10.1172\/JCI163235.","DOI":"10.1172\/JCI163235"},{"key":"10.1016\/j.rdc.2023.03.002_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.793197","article-title":"SARS-CoV-2-Specific T\u00a0cell responses are stronger in children with multisystem inflammatory syndrome compared to children with uncomplicated SARS-CoV-2 infection. original research","volume":"12","author":"Conway","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.rdc.2023.03.002_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146614","article-title":"HLA class I-associated expansion of TRBV11-2 T\u00a0cells in multisystem inflammatory syndrome in children","volume":"131","author":"Porritt","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.rdc.2023.03.002_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-022-01724-3","article-title":"Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19","author":"Sacco","year":"2022","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.rdc.2023.03.002_bib35","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211381","article-title":"TIM3+ TRBV11-2 T\u00a0cells and IFN\u03b3 signature in patrolling monocytes and CD16+ NK cells delineate MIS-C","volume":"219","author":"Hoste","year":"2022","journal-title":"J\u00a0Exp Med"},{"issue":"59","key":"10.1016\/j.rdc.2023.03.002_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh1516","article-title":"Polyclonal expansion of TCR Vbeta 21.3(+) CD4(+) and CD8(+) T\u00a0cells is a hallmark of Multisystem Inflammatory Syndrome in Children","volume":"6","author":"Moreews","year":"2021","journal-title":"Sci Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2023.03.002_bib37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The immunology of multisystem inflammatory syndrome in children with COVID-19","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12969-021-00511-7","article-title":"Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey","volume":"19","author":"Cattalini","year":"2021","journal-title":"Pediatr Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2023.03.002_bib39","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1093\/rheumatology\/keab026","article-title":"Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review","volume":"60","author":"Cherqaoui","year":"2021","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.rdc.2023.03.002_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144554","article-title":"Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease","volume":"131","author":"Esteve-Sole","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"17","key":"10.1016\/j.rdc.2023.03.002_bib41","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.jacc.2020.08.056","article-title":"Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States","volume":"76","author":"Matsubara","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.rdc.2023.03.002_bib42","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/art.42062","article-title":"American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-","volume":"74","author":"Henderson","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"21","key":"10.1016\/j.rdc.2023.03.002_bib43","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.jacc.2009.04.102","article-title":"When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood","volume":"54","author":"Gordon","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.rdc.2023.03.002_bib44","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-051155","article-title":"Longitudinal outcomes for multisystem inflammatory syndrome in children","volume":"148","author":"Farooqi","year":"2021","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.rdc.2023.03.002_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/apc.APC_172_16","article-title":"Long-term outcome of coronary artery dilatation in Kawasaki disease","volume":"11","author":"Advani","year":"2018","journal-title":"Ann Pediatr Cardiol"},{"issue":"4","key":"10.1016\/j.rdc.2023.03.002_bib46","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-050973","article-title":"Six month follow-up of patients with multi-system inflammatory syndrome in children","volume":"148","author":"Capone","year":"2021","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.rdc.2023.03.002_bib47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","article-title":"Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C)","volume":"183","author":"Gruber","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.rdc.2023.03.002_bib48","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41591-020-1054-6","article-title":"Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection","volume":"26","author":"Carter","year":"2020","journal-title":"Nat Med"},{"issue":"57","key":"10.1016\/j.rdc.2023.03.002_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf7570","article-title":"Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19","volume":"6","author":"Vella","year":"2021","journal-title":"Sci Immunol"},{"issue":"20","key":"10.1016\/j.rdc.2023.03.002_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151520","article-title":"The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children","volume":"131","author":"Porritt","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.rdc.2023.03.002_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac070","article-title":"Serologic and cytokine signatures in children with multisystem inflammatory syndrome and coronavirus disease 2019","volume":"9","author":"Lapp","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.rdc.2023.03.002_bib52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0090-1229(88)90088-8","article-title":"Peripheral blood monocyte\/macrophages and serum tumor necrosis factor in Kawasaki disease","volume":"48","author":"Furukawa","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0090-1229(90)90166-N","article-title":"Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions","volume":"56","author":"Matsubara","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.rdc.2023.03.002_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01963561","article-title":"The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease","volume":"150","author":"Lin","year":"1991","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib55","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1038\/s41467-022-30357-w","article-title":"An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease","volume":"13","author":"Ghosh","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.rdc.2023.03.002_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cct.2016.04.002","article-title":"Rationale and study design for a phase I\/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial)","volume":"48","author":"Tremoulet","year":"2016","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.41481","article-title":"Phase II open label study of anakinra in intravenous immunoglobulin-resistant Kawasaki disease","volume":"73","author":"Kon\u00e9-Paut","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2249.2010.04236.x","article-title":"The T helper type 17\/regulatory T\u00a0cell imbalance in patients with acute Kawasaki disease","volume":"162","author":"Jia","year":"2010","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2023.03.002_bib59","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.immuni.2021.04.003","article-title":"Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children","volume":"54","author":"Ramaswamy","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib60","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1038\/s41467-021-25771-5","article-title":"Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.rdc.2023.03.002_bib61","doi-asserted-by":"crossref","first-page":"100848","DOI":"10.1016\/j.xcrm.2022.100848","article-title":"Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children","volume":"3","author":"Boribong","year":"2022","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.rdc.2023.03.002_bib62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1442-200x.2005.02049.x","article-title":"Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease","volume":"47","author":"Takahashi","year":"2005","journal-title":"Pediatr Int"},{"key":"10.1016\/j.rdc.2023.03.002_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41390-019-0710-3","article-title":"Enhanced formation of neutrophil extracellular traps in Kawasaki disease","author":"Yoshida","year":"2020","journal-title":"Pediatr Res"},{"issue":"94","key":"10.1016\/j.rdc.2023.03.002_bib64","article-title":"Antibodies and immunity during Kawasaki disease. Review","volume":"7","author":"Hicar","year":"2020","journal-title":"Frontiers Cardiovasc Medicine"},{"issue":"5","key":"10.1016\/j.rdc.2023.03.002_bib65","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/S2665-9913(22)00064-9","article-title":"Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study","volume":"4","author":"Pfeifer","year":"2022","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib66","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.immunol.17.1.435","article-title":"The structural basis of t\u00a0cell activation by superantigens","volume":"17","author":"Li","year":"1999","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2023.03.002_bib67","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2249.1995.tb05545.x","article-title":"Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells","volume":"99","author":"Sakaguchi","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2023.03.002_bib68","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.4049\/jimmunol.153.4.1881","article-title":"TCR V beta family repertoire and T\u00a0cell activation markers in Kawasaki disease","volume":"153","author":"Pietra","year":"1994","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2023.03.002_bib69","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-3083.1998.00415.x","article-title":"Characterization of the T-cell receptor V-beta repertoire in Kawasaki disease","volume":"48","author":"Mancia","year":"1998","journal-title":"Scand J Immunol"},{"issue":"6 Pt 2","key":"10.1016\/j.rdc.2023.03.002_bib70","doi-asserted-by":"crossref","first-page":"852","DOI":"10.7326\/0003-4819-96-6-852","article-title":"Pathologic findings in twelve fatal cases of toxic shock syndrome","volume":"96","author":"Paris","year":"1982","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaci.2020.10.008","article-title":"COVID-19-associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome-the superantigen hypothesis","volume":"147","author":"Noval Rivas","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.rdc.2023.03.002_bib72","doi-asserted-by":"crossref","first-page":"941009","DOI":"10.3389\/fimmu.2022.941009","article-title":"Multisystem inflammatory syndrome in children and long COVID: the SARS-CoV-2 viral superantigen hypothesis","volume":"13","author":"Noval Rivas","year":"2022","journal-title":"Front Immunol"},{"issue":"41","key":"10.1016\/j.rdc.2023.03.002_bib73","doi-asserted-by":"crossref","first-page":"25254","DOI":"10.1073\/pnas.2010722117","article-title":"Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation","volume":"117","author":"Cheng","year":"2020","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"9","key":"10.1016\/j.rdc.2023.03.002_bib74","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.str.2021.04.005","article-title":"A\u00a0monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in\u00a0vitro","volume":"29","author":"Cheng","year":"2021","journal-title":"Structure"},{"issue":"7849","key":"10.1016\/j.rdc.2023.03.002_bib75","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-021-03237-4","article-title":"Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis","volume":"591","author":"Johnson","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib76","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/22221751.2020.1756700","article-title":"Attenuated SARS-CoV-2 variants with deletions at the S1\/S2 junction","volume":"9","author":"Lau","year":"2020","journal-title":"Emerg Microb Infect"},{"issue":"10","key":"10.1016\/j.rdc.2023.03.002_bib77","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2352-4642(20)30257-1","article-title":"SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome","volume":"4","author":"Dolhnikoff","year":"2020","journal-title":"Lancet Child Adolesc Heal"},{"key":"10.1016\/j.rdc.2023.03.002_bib78","doi-asserted-by":"crossref","first-page":"100850","DOI":"10.1016\/j.eclinm.2021.100850","article-title":"An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-C","volume":"35","author":"Duarte-Neto","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.rdc.2023.03.002_bib79","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpeds.2021.11.058","article-title":"SARS-CoV-2 Spike protein in intestinal cells of a patient with coronavirus disease 2019 multisystem inflammatory syndrome","volume":"243","author":"Mayordomo-Colunga","year":"2022","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2023.03.002_bib80","doi-asserted-by":"crossref","first-page":"154106","DOI":"10.1016\/j.prp.2022.154106","article-title":"Multisystem inflammatory syndrome in children (MIS-C) showing disseminated aspergillosis, cytomegalovirus reactivation and persistent SARS-COV-2: Case report with autopsy review","volume":"238","author":"Taweevisit","year":"2022","journal-title":"Pathol Res Pract"},{"issue":"14","key":"10.1016\/j.rdc.2023.03.002_bib81","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149633","article-title":"Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier","volume":"131","author":"Yonker","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.rdc.2023.03.002_bib82","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.rdc.2023.03.002_bib83","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jcin.2015.12.011","article-title":"The spectrum of cardiovascular lesions requiring intervention in adults after Kawasaki disease","volume":"9","author":"Gordon","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archpedi.156.1.77","article-title":"Long-term consequences of Kawasaki disease among first-year junior high school students","volume":"156","author":"Hirata","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"10.1016\/j.rdc.2023.03.002_bib85","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00246-007-9062-6","article-title":"Detectable silent calcification in a regressed coronary artery aneurysm of a young adult with a history of Kawasaki disease","volume":"29","author":"Muneuchi","year":"2008","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.rdc.2023.03.002_bib86","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2021.08.003","article-title":"The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives","volume":"243","author":"Truong","year":"2022","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.rdc.2023.03.002_bib87","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-057798","article-title":"Health impairments in children and adolescents after hospitalization for acute COVID-19 or MIS-C","volume":"150","author":"Maddux","year":"2022","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.rdc.2023.03.002_bib88","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamapediatrics.2021.2993","article-title":"One-year outcomes of critical care patients post\u2013COVID-19 multisystem inflammatory syndrome in children","volume":"175","author":"Davies","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"7","key":"10.1016\/j.rdc.2023.03.002_bib89","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S2352-4642(21)00138-3","article-title":"6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study","volume":"5","author":"Penner","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.rdc.2023.03.002_bib90","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra2206573","article-title":"Covid-19 vaccines \u2014 immunity, variants, boosters","author":"Barouch","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.rdc.2023.03.002_bib91","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1001\/jama.2022.8025","article-title":"Severity and incidence of multisystem inflammatory syndrome in children during 3 SARS-CoV-2 Pandemic Waves in Israel","volume":"327","author":"Levy","year":"2022","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.rdc.2023.03.002_bib92","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapediatrics.2022.2206","article-title":"Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave","volume":"176","author":"Holm","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.rdc.2023.03.002_bib93","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15585\/mmwr.mm7102e1","article-title":"Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18 years - United States, July-December 2021","volume":"71","author":"Zambrano","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.rdc.2023.03.002_bib94","doi-asserted-by":"crossref","first-page":"110829","DOI":"10.1016\/j.celrep.2022.110829","article-title":"Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant","volume":"39","author":"Liu","year":"2022","journal-title":"Cell Rep"},{"issue":"7902","key":"10.1016\/j.rdc.2023.03.002_bib95","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2023.03.002_bib96","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3389\/fimmu.2018.02422","article-title":"Dynamics of inflammatory response in autoinflammatory disorders: autonomous and hyperinflammatory states","volume":"9","author":"G\u00fcl","year":"2018","journal-title":"Front Immunol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:30:50Z","timestamp":1760182250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X23000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0889857X23000339"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2023.03.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kawasaki Disease and Multisystem Inflammatory Syndrome in Children","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}